Skip to main content

Table 2 Clinicopathologic characteristics of patients who underwent resection for colorectal cancer liver metastases stratified for the administration of adjuvant therapy

From: Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy

  No adjuvant CTx Adjuvant CTx Pvalue
n 181 (61) 116 (39)  
Gender    0.11
 Male 115 (64) 84 (72)
 Female 66 (36) 32 (28)
Age [years] 64 (30 – 88) 63 (33 – 83) 0.03
Initial stage of disease (UICC)    0.53
 I 23 (7) 9 (8)
 II 37 (21) 17 (15)
 III 56 (32) 36 (31)
 IV 70 (40) 53 (46)
Site of primary tumor    0.14
 Colon 95 (52) 71 (61)
 Rectum 86 (47) 45 (39)
CEA level [μg/l) 12.6 (0.6 – 2032) 18.1 (0.5 – 7606) 0.63
Number of metastases    0.72
 1 99 (55) 61 (53)
 > 1 82 (45) 55 (47)
Size of largest metastasis    0.06
 < 5 cm 95 (52) 48 (41)
 ≥ 5 cm 86 (48) 68 (59)
Distribution of metastases    0.08
 Unilobar 120 (67) 66 (57)
 Bilobar 60 (33) 55 (43)
MSKCC clinical risk score    0.07
 ≤ 2 111 (61) 60 (52)
 > 2 69 (39) 56 (48)  
  1. Data are presented as n (%) or median (range). CTx, Chemotherapy.